Product nameAnti-Bestrophin/BEST1 antibody
See all Bestrophin/BEST1 primary antibodies
DescriptionRabbit polyclonal to Bestrophin/BEST1
Tested applicationsSuitable for: IP, WB, ICC, ICC/IFmore details
Species reactivityReacts with: Mouse, Rat, Cow, Human
Predicted to work with: Cynomolgus monkey
- Conditioned medium cultured RPE cells (the basal expression of Bestrophin/BEST1 is low in cultured cells).
This product was previously labelled as Bestrophin
Storage instructionsShipped at 4°C. Upon delivery aliquot and store at -20°C or -80°C. Avoid repeated freeze / thaw cycles.
Storage bufferpH: 7.40
Preservative: 0.02% Sodium azide
Constituents: Tris glycine, 0.5% BSA, 30% Glycerol
Concentration information loading...
PurityImmunogen affinity purified
Our Abpromise guarantee covers the use of ab14927 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
WB: 1/500. Predicted molecular weight: 68 kDa.
Not tested in other applications.
Optimal dilutions/concentrations should be determined by the end user.
FunctionForms calcium-sensitive chloride channels. Highly permeable to bicarbonate.
Tissue specificityPredominantly expressed in the basolateral membrane of the retinal pigment epithelium.
Involvement in diseaseDefects in BEST1 are the cause of vitelliform macular dystrophy type 2 (VMD2) [MIM:153700]; also known as Best macular dystrophy (BMD). VMD2 is an autosomal dominant form of macular degeneration that usually begins in childhood or adolescence. VMD2 is characterized by typical 'egg-yolk' macular lesions due to abnormal accumulation of lipofuscin within and beneath the retinal pigment epithelium cells. Progression of the disease leads to destruction of the retinal pigment epithelium and vision loss.
Defects in BEST1 are the cause of retinitis pigmentosa type 50 (RP50) [MIM:613194]. A retinal dystrophy belonging to the group of pigmentary retinopathies. RP is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well.
Defects in BEST1 are a cause of adult-onset vitelliform macular dystrophy (AVMD) [MIM:608161]. AVMD is a rare autosomal dominant disorder with incomplete penetrance and highly variable expression. Patients usually become symptomatic in the fourth or fifth decade of life with a protracted disease of decreased visual acuity.
Defects in BEST1 are the cause of bestrophinopathy autosomal recessive (ARB) [MIM:611809]. A retinopathy characterized by central visual loss, an absent electro-oculogram light rise, and a reduced electroretinogram.
Defects in BEST1 are the cause of vitreoretinochoroidopathy autosomal dominant (ADVIRC) [MIM:193220]. A disorder characterized by vitreoretinochoroidal dystrophy. The clinical presentation is variable and may be associated with cataract, nanophthalmos, microcornea, shallow anterior chamber, and glaucoma.
Sequence similaritiesBelongs to the bestrophin family.
modificationsPhosphorylated by PP2A.
Cellular localizationCell membrane. Basolateral cell membrane.
- Information by UniProt
- ARB antibody
- BEST 1 antibody
- BEST antibody
ab14927 staining HEK-293 cells transfected with human Bestrophin/BEST1 1 by ICC/IF. Cells were PFA fixed and permeabilized in 0.5% Triton X-100 prior to blocking in 5% goat serum for 20 minutes at 25°C. The primary antibody was diluted 1/100 and incubated with the sample for 12 hours at 4°C. An Alexa Fluor® 488 conjugated goat anti-rabbit antibody was used as the secondary. Bestrophin/BEST1 transfected in HEK-293 cells is labeled with green fluorescence. Nuclei were counterstained with DAPI (blue).
All lanes : Anti-Bestrophin/BEST1 antibody (ab14927) at 1/200 dilution
Lane 1 : Whole cell lysate from bovine retinal pigment epithelial cells
Lane 2 : Whole cell lysate from non transfected HEK 293 cells
Lysates/proteins at 25 µg per lane.
All lanes : HRP conjugated goat anti-rabbit at 1/5000 dilution
Developed using the ECL technique.
Performed under reducing conditions.
Predicted band size: 68 kDa
Observed band size: 68 kDa
Additional bands at: 74 kDa (possible non-specific binding)
Exposure time: 20 minutes
The primary antibody was incubated with the membrane for 12 hours at 4°C.
This product has been referenced in:
- Geng Z et al. Generation of retinal pigmented epithelium from iPSCs derived from the conjunctiva of donors with and without age related macular degeneration. PLoS One 12:e0173575 (2017). Read more (PubMed: 28282420) »
- Lin YH et al. Opening a New Time Window for Treatment of Stroke by Targeting HDAC2. J Neurosci 37:6712-6728 (2017). Read more (PubMed: 28592694) »